AU2023250008A1 - Crystalline forms of a macrocyclic peptide antibiotic - Google Patents
Crystalline forms of a macrocyclic peptide antibiotic Download PDFInfo
- Publication number
- AU2023250008A1 AU2023250008A1 AU2023250008A AU2023250008A AU2023250008A1 AU 2023250008 A1 AU2023250008 A1 AU 2023250008A1 AU 2023250008 A AU2023250008 A AU 2023250008A AU 2023250008 A AU2023250008 A AU 2023250008A AU 2023250008 A1 AU2023250008 A1 AU 2023250008A1
- Authority
- AU
- Australia
- Prior art keywords
- theta
- wavenumbers
- xrpd
- absorption bands
- atr
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/08—Tripeptides
- C07K5/0815—Tripeptides with the first amino acid being basic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Pharmacology & Pharmacy (AREA)
- Communicable Diseases (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP22167057.3 | 2022-04-07 | ||
| EP22167057 | 2022-04-07 | ||
| PCT/EP2023/058906 WO2023194418A1 (en) | 2022-04-07 | 2023-04-05 | Crystalline forms of a macrocyclic peptide antibiotic |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2023250008A1 true AU2023250008A1 (en) | 2024-10-03 |
Family
ID=81448543
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2023250008A Pending AU2023250008A1 (en) | 2022-04-07 | 2023-04-05 | Crystalline forms of a macrocyclic peptide antibiotic |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP4504749A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2025511869A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20240169690A (cg-RX-API-DMAC7.html) |
| CN (1) | CN118974073A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2023250008A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3255726A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL315686A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2024012228A (cg-RX-API-DMAC7.html) |
| TW (1) | TW202404991A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023194418A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2026154152A1 (en) * | 2025-01-20 | 2026-07-23 | F. Hoffmann-La Roche Ag | Pharmaceutical compositions comprising an antibiotic macrocyclic peptide |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11819532B2 (en) | 2018-04-23 | 2023-11-21 | Hoffmann-La Roche Inc. | Peptide macrocycles against Acinetobacter baumannii |
-
2023
- 2023-04-05 WO PCT/EP2023/058906 patent/WO2023194418A1/en not_active Ceased
- 2023-04-05 JP JP2024559427A patent/JP2025511869A/ja active Pending
- 2023-04-05 KR KR1020247036516A patent/KR20240169690A/ko active Pending
- 2023-04-05 CN CN202380032881.2A patent/CN118974073A/zh active Pending
- 2023-04-05 CA CA3255726A patent/CA3255726A1/en active Pending
- 2023-04-05 AU AU2023250008A patent/AU2023250008A1/en active Pending
- 2023-04-05 EP EP23718634.1A patent/EP4504749A1/en active Pending
- 2023-04-05 IL IL315686A patent/IL315686A/en unknown
- 2023-04-06 TW TW112112829A patent/TW202404991A/zh unknown
-
2024
- 2024-10-03 MX MX2024012228A patent/MX2024012228A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN118974073A (zh) | 2024-11-15 |
| CA3255726A1 (en) | 2023-10-12 |
| EP4504749A1 (en) | 2025-02-12 |
| IL315686A (en) | 2024-11-01 |
| MX2024012228A (es) | 2024-11-08 |
| WO2023194418A1 (en) | 2023-10-12 |
| TW202404991A (zh) | 2024-02-01 |
| KR20240169690A (ko) | 2024-12-03 |
| JP2025511869A (ja) | 2025-04-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2009245817B2 (en) | Organic compounds | |
| EP2753613B1 (en) | Derivatives of xanthone compounds | |
| CN107056813B (zh) | 德罗格韦钠盐的晶型及其制备方法 | |
| CN105061358A (zh) | 甲基锍氯化物结晶水合物 | |
| EP4504749A1 (en) | Crystalline forms of a macrocyclic peptide antibiotic | |
| ES2553165T3 (es) | Preparación de un antibiótico cristalino de ácido fusídico | |
| HK40114674A (en) | Crystalline forms of a macrocyclic peptide antibiotic | |
| CN110938114A (zh) | 一类万古霉素硫鎓衍生物、其制备方法、药物组合物和用途 | |
| NZ577978A (en) | The fumarate salt of 3-benzyl-2-methyl-2,3,3a,4,5,6,7,7a-octahydrobenzo[d]isoxazol-4-one | |
| CN114466652A (zh) | (r)-2-[2-氨基-3-(吲哚-3-基)丙酰基氨基]-2-甲基丙酸的新型多晶型物晶型及其用途 | |
| CZ217694A3 (en) | 3/2 hydrate and anhydrate of 7-/(7-(s)-amino-5-azaspiro/2.4/heptan-5-yl/-8-chloro-6-fluoro-1-/(1r,2s) 2-fluorocyclopropyl/-4-oxo-1,4-dihydroquinoline-3-carboxylic acid, processes of selective production of 3/2 hydrate, crystals thereof and antibacterial agents based thereon | |
| US20250171428A1 (en) | Crystalline forms of 6-((5-methyl-3-(6-methylpyridin-3-yl)isoxazol-4- yl)methoxy)- n -(tetrahydrapyran-4-yl)pyridazine-3-carboxamide | |
| US20110144154A1 (en) | Salts of 2-Substituted Quinolines | |
| HK40114727A (en) | Crystalline forms of 6-((5-methyl-3-(6-methylpyridin-3-yl)isoxazol-4-yl)methoxy)-n-(tetrahydrapyran-4-yl)pyridazine-3-carboxamide |